Allogene Therapeutics: Custom Supplier Solutions - Collaborate with Miltenyi

Allogene Therapeutics, in collaboration with T&L Biotechnology Co., Ltd., is proud to introduce our latest innovation in Cell Therapy. Our companies have joined forces to develop cutting-edge allogeneic CAR-T technology, offering a transformative approach to cancer treatment, Our proprietary platform leverages the power of allogeneic cell therapy, allowing for the creation of off-the-shelf CAR-T products. By using healthy donor cells, we can produce a consistent and scalable supply of CAR-T treatments, eliminating the need for individualized production for each patient, This breakthrough technology not only streamlines the manufacturing process but also expands accessibility to CAR-T therapy for a larger patient population. Our mission is to make this revolutionary treatment option available to as many patients as possible, ultimately improving outcomes and advancing the fight against cancer, With an unwavering commitment to innovation and patient care, Allogene Therapeutics and T&L Biotechnology Co., Ltd. strive to redefine the future of cancer treatment through allogeneic cell therapy